Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-044390
Filing Date
2017-12-20
Accepted
2017-12-20 12:39:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 99004
  Complete submission text file 0000000000-17-044390.txt   137378
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filed for) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)